Edgewise Therapeutics Inc... (EWTX)
NASDAQ: EWTX
· Real-Time Price · USD
14.15
0.22 (1.58%)
At close: Aug 15, 2025, 3:59 PM
14.31
1.10%
After-hours: Aug 15, 2025, 05:00 PM EDT
Edgewise Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 2.12M | n/a | n/a | n/a | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 567K | 554K | 1.06M | 2.29M | 534K | 525K | 533K | 448K | 437K | 241K | 92K | 165K | 154K | 127K | 78K | 64K | 51K | 79K |
Gross Profit | -567K | -554K | 1.06M | -2.29M | -534K | -525K | 1.72M | -448K | -437K | -241K | -92K | -165K | -154K | -127K | -78K | -64K | -51K | -79K |
Operating Income | -42.61M | -45.96M | -45.54M | -40.43M | -38.11M | -34.75M | -33.86M | -29.45M | -25.34M | -25.7M | -22.08M | -18.26M | -16.49M | -14.83M | -12.82M | -13.08M | -10.46M | -6.86M |
Interest Income | 6.5M | 5.16M | 5.88M | 6.3M | 6.61M | 6.23M | 3.72M | 3.74M | 3.87M | 2.87M | 2.66M | 764K | 424K | 166K | 126K | 127K | 107K | 42K |
Pretax Income | -36.12M | -40.8M | -39.66M | -34.13M | -31.5M | -28.52M | -30.14M | -25.71M | -21.47M | -22.84M | -19.41M | -17.5M | -16.07M | -14.66M | -12.7M | -12.95M | -10.35M | -6.82M |
Net Income | -36.12M | -40.8M | -39.66M | -34.13M | -31.5M | -28.52M | -30.14M | -25.71M | -21.47M | -19.73M | -16.75M | -16.73M | -15.64M | -14.49M | -12.7M | -12.95M | -10.35M | -6.82M |
Selling & General & Admin | 9.05M | 9.2M | 9.28M | 8.21M | 7.37M | 7.01M | 6.18M | 5.67M | 5.78M | 5.83M | 5.47M | 4.37M | 4.09M | 3.7M | 3.73M | 3.2M | 2.6M | 1.5M |
Research & Development | 33.56M | 36.76M | 37.32M | 32.22M | 30.2M | 27.22M | 27.68M | 23.79M | 19.56M | 19.88M | 16.61M | 13.89M | 12.4M | 11.12M | 9.09M | 9.88M | 7.86M | 5.36M |
Other Expenses | n/a | n/a | -1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.61M | 45.96M | 45.54M | 40.43M | 37.57M | 34.23M | 33.86M | 29.45M | 25.34M | 25.7M | 22.08M | 18.26M | 16.49M | 14.83M | 12.82M | 13.08M | 10.46M | 6.86M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 106K | n/a | -54K | -52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 42.61M | 45.96M | 45.54M | 40.43M | 38.11M | 34.75M | 33.86M | 29.45M | 25.34M | 25.7M | 22.08M | 18.26M | 16.49M | 14.83M | 12.82M | 13.08M | 10.46M | 6.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.11M | -2.66M | -764K | -424K | -166K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 104.94M | 95.13M | 92.41M | 93.81M | 93.52M | 87.57M | 64.77M | 63.46M | 63.38M | 63.27M | 63.23M | 51.84M | 49.62M | 49.54M | 49.26M | 49.26M | 49.26M | 1.56M |
Shares Outstanding (Diluted) | 104.94M | 95.13M | 92.41M | 93.81M | 93.52M | 87.57M | 64.77M | 63.46M | 63.38M | 63.27M | 63.23M | 51.84M | 49.62M | 49.54M | 49.26M | 49.26M | 49.26M | 1.56M |
EPS (Basic) | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 | -0.31 | -0.26 | -0.32 | -0.32 | -0.29 | -0.26 | -0.26 | -0.21 | -4.37 |
EPS (Diluted) | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 | -0.31 | -0.26 | -0.32 | -0.32 | -0.29 | -0.26 | -0.26 | -0.21 | -4.37 |
EBITDA | -42.61M | -45.96M | -39.03M | -39.83M | -37.63M | -34.28M | -33.38M | -29M | -24.91M | -25.51M | -21.99M | -18.16M | -16.39M | -14.7M | -12.74M | -13.01M | -10.41M | -6.78M |
EBIT | -36.12M | -40.8M | -39.66M | -40.43M | -38.11M | -34.75M | -33.86M | -29.45M | -25.34M | -25.7M | -22.08M | -18.26M | -16.49M | -14.83M | -12.82M | -13.08M | -10.46M | -6.86M |
Depreciation & Amortization | n/a | 554K | 629K | 602K | 534K | 525K | 533K | 448K | 437K | 241K | 92K | 165K | 154K | 127K | 78K | 64K | 51K | 79K |